Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
In SURMOUNT2, eligible study participants were randomized to receive once weekly tirzepatide 10, 15 mg or a matching placebo for 72 weeks
Addressing insulin resistance is crucial in the context of obesity, given its key contribution to the onset of numerous chronic conditions, including T2D, atherosclerosis, non-alcoholic fatty liver disease (NAFLD), and polycystic ovary syndrome (PCOS), among others [14]
The most common side effects affect the injection site, and may include: If you experience any of these symptoms, its important to speak with a healthcare professional
By entering I agree to the Terms and Conditions
Many patients in medically supervised programs not only lose weight but also see improvements in related health issues, such as type 2 diabetes, high blood pressure, elevated cholesterol, and sleep apnea
US$ 23.78
US$ 28.78
US$ 26.32
US$ 28.02
US$ 28.10
US$ 20.10
